News
GlobalData on MSN8d
Enrolment concludes in EyePoint’s Phase III programme of Duravyu for wet AMDEyePoint Pharmaceuticals has concluded subject enrolment in the pivotal Phase III programme assessing Duravyu, aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback